Company: UONE
Filing Date: 2025-02-12
Form Type: 8-K
Source: 0001041657-25-000007
Chunk: 0

Company: URBAN ONE, INC.
Filing Date: 2025-02-12
Form: 8-K
Item: Item 3.01
Chunk 0
---
ITEM 3.01 NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING.

On February 11, 2025, Urban One Inc. (the “ Company”) received written notice (the “ Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Class D common stock, par value $0.001 per share (the “ Class D Common Stock”) had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “ Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing of the Class D Common Stock, which continues to trade on the Nasdaq Capital Market under the symbol “ UONEK”. The Notice also has no impact on the Company’s Class A Common Stock which trades under the symbol “ UONE.”

In accordance with Nasdaq Listing Rule 5810(c) (3) (A), the Company has a period of 180 calendar days, or until August 11, 2025, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company’s Class D Common Stock must be at least $1.00 per share for a minimum of ten (10) consecutive business days as required under Nasdaq Listing Rule 5810(c) (3) (A) (unless the Nasdaq staff exercises its discretion to extend this ten-day period pursuant to Nasdaq Listing Rule 5810(c) (3) (H)) during the 180-day period prior to August 11, 2025.

In the event the Company does not regain compliance prior to August 11, 2025, the Company may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears that the Company will not be able to cure the